Results 181 to 190 of about 3,698,572 (312)

Denmark Media, Internet & Telecommunications Complete Profile This All-Inclusive Profile Includes All Three of Our Communications Reports

open access: yes
Get all three comprehensive reports bundled into one for a complete media and communications profile of Denmark. An excellent source of practical information, this profile offers an extensive dialing guide with city codes, a listing of ISPs and Internet ...
Press, World Trade.
core  

Profile of a profiler

open access: yesMaterials Today, 2002
openaire   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Belarus Media, Internet & Telecommunications Complete Profile This All-Inclusive Profile Includes All Three of Our Communications Reports

open access: yes
Get all three comprehensive reports bundled into one for a complete media and communications profile of Belarus. An excellent source of practical information, this profile offers an extensive dialing guide with city codes, a listing of ISPs and Internet ...
Press, World Trade.
core  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Burundi Media, Internet & Telecommunications Complete Profile This All-Inclusive Profile Includes All Three of Our Communications Reports

open access: yes
Get all three comprehensive reports bundled into one for a complete media and communications profile of Burundi. An excellent source of practical information, this profile offers an extensive dialing guide with city codes, a listing of ISPs and Internet ...
Press, World Trade.
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Latvia Media, Internet & Telecommunications Complete Profile This All-Inclusive Profile Includes All Three of Our Communications Reports

open access: yes
Get all three comprehensive reports bundled into one for a complete media and communications profile of Latvia. An excellent source of practical information, this profile offers an extensive dialing guide with city codes, a listing of ISPs and Internet ...
Press, World Trade.
core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy